NVS Kronos AI forecast
A 30-trading-day price forecast for Novartis AG (NVS) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Novartis AG at $150.68 on 2026-12-08, −3.9% from the last close of $156.86 on 2026-10-27. Eight out of ten sampled paths end between $147.52 and $154.79, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of NVS
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $161.48 | $159.27 | $164.62 |
| 2026-11-10 | $160.04 | $157.55 | $164.90 |
| 2026-11-17 | $151.62 | $148.45 | $155.94 |
| 2026-11-24 | $152.02 | $149.69 | $153.43 |
| 2026-12-01 | $151.96 | $149.29 | $154.77 |
| 2026-12-08 | $150.68 | $147.52 | $154.79 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for NVS?
- Kronos AI's median forecast for NVS is $150.68 in 30 trading days, −3.9% from the last close, with a 10–90% range of $147.52 to $154.79.
- Is the NVS Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- AZN — AstraZeneca PLC
- ABT — Abbott Laboratories